Verve Therapeutics, Inc.

Q4 2024 13F Holders

Symbol
VERV
CUSIP
92539P101
Type
Equity
Class
COM
Num filings
176
Total reported value, excl. options
$444 M
Manager Report Date Value ($000) Shares Option Type